GNH USA

Europe — EMA

Miostin (Neostigmine Methylsulfate)

GNH USA supplies Miostin (Neostigmine Methylsulfate), a acetylcholinesterase inhibitor for myasthenia gravis, reversal of neuromuscular blockade

Neostigmine Methylsulfate

Request sourcing

1
Pack/s

What is Neostigmine Methylsulfate?

Neostigmine methylsulfate, the active ingredient in Miostin, is an acetylcholinesterase inhibitor presented as a sterile injectable solution for intramuscular, intravenous, and subcutaneous use. It treats myasthenia gravis, reverses non‑depolarizing neuromuscular blockade, and aids postoperative ileus in appropriate patients.

GNH USA supplies Miostin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Neostigmine Methylsulfate used for?

Miostin acts on the cholinergic neuromuscular pathway and is employed for several recognized clinical conditions.

Myasthenia gravis: improves muscle strength by enhancing neuromuscular transmission. Reversal of non‑depolarizing neuromuscular blockade: restores spontaneous breathing after surgery. Postoperative ileus: stimulates gastrointestinal motility to shorten ileus duration.

What are the side effects of Neostigmine Methylsulfate?

Adverse reactions may occur with Miostin and should be monitored.

Common Side Effects: - Muscle cramps - Increased salivation - Sweating - Nausea - Abdominal discomfort - Urinary urgency

Serious or Rare Side Effects: - Bradycardia - Bronchospasm - Severe hypotension - Cholinergic crisis - Allergic anaphylaxis - Seizures

What precautions apply to Neostigmine Methylsulfate?

Miostin requires careful use in specific patient groups and clinical situations.

Dose adjustment in renal impairment: reduce dose as needed. Monitor for signs of cholinergic excess: muscle twitching, sweating, or gastrointestinal upset. Avoid in patients with known hypersensitivity to neostigmine or formulation components. Caution in asthma or COPD: risk of bronchospasm. Store at ambient temperature: keep in original container, protect from light and moisture.

What does Neostigmine Methylsulfate interact with?

Miostin can interact with several medicines; some combinations should be avoided while others need close monitoring.

Major Interactions (Avoid): - Anticholinergic drugs: may reduce therapeutic efficacy. - Beta‑blockers: can exacerbate bradycardia. - Magnesium sulfate: potentiates neuromuscular effects. - Succinylcholine: risk of prolonged blockade.

Moderate Interactions (Monitor Closely): - Volatile anesthetic agents: may enhance cholinergic activity. - Cardiac glycosides: monitor heart rate and rhythm. - Diuretics: watch for electrolyte disturbances.

Frequently asked questions

What is Miostin used for?+
Miostin contains neostigmine methylsulfate and is prescribed for conditions such as myasthenia gravis, reversal of non‑depolarizing neuromuscular blockade after surgery, and postoperative ileus. It works by enhancing cholinergic transmission at neuromuscular junctions, thereby improving muscle strength and gastrointestinal motility where appropriate.
How does neostigmine methylsulfate work?+
Neostigmine methylsulfate is a reversible acetylcholinesterase inhibitor. By binding to the enzyme acetylcholinesterase, it prevents the breakdown of acetylcholine, leading to increased concentrations of this neurotransmitter at neuromuscular junctions and in autonomic synapses. The elevated acetylcholine enhances muscle contraction and stimulates smooth‑muscle activity, which underlies its therapeutic effects.
What is the usual dose of Miostin?+
The dosage of Miostin is individualized by the prescribing clinician based on the specific indication, patient weight, renal function, and clinical response. Healthcare professionals calculate the appropriate amount and route (intravenous, intramuscular, or subcutaneous) and adjust as needed during treatment. Patients should follow the prescriber's instructions and not alter the dose on their own.
Is Miostin safe during pregnancy or breastfeeding?+
Safety data for neostigmine methylsulfate in pregnancy and lactation are limited, and the product is generally classified as a category where benefits must be weighed against potential risks. Clinicians should consider alternative therapies when possible and use Miostin only if clearly needed. Breastfeeding mothers should consult their physician before use.
How do I order Miostin from GNH USA?+
To request Miostin, visit the product page on gnh-usa.com, enter the desired quantity, and submit the inquiry form. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing a quotation, availability details, shipping options (including cold‑chain if required), and necessary import documentation.
How does Miostin compare with other anticholinesterase agents?+
Miostin (neostigmine methylsulfate) is a quaternary ammonium compound, offering rapid onset when administered intravenously and limited ability to cross the blood‑brain barrier, reducing central side effects compared with physostigmine. Compared with pyridostigmine, neostigmine has a shorter duration of action, making it suitable for acute reversal of neuromuscular blockade rather than chronic management.
What are the storage requirements for Miostin?+
Miostin should be stored at ambient temperature, preferably below 25 °C, in its original sealed container. Protect the product from direct sunlight, moisture, and extreme temperature fluctuations. Do not freeze the solution. Follow any additional handling instructions provided by the supplier to maintain product integrity.
How is Miostin administered?+
Miostin is supplied as a sterile injectable solution for intramuscular, intravenous, or subcutaneous injection. The route and rate of administration are determined by the treating physician, often based on the clinical situation—e.g., rapid intravenous bolus for neuromuscular blockade reversal or slower infusion for myasthenic patients. Proper aseptic technique and appropriate dilution, if required, should be observed.
What are the most serious risks associated with Miostin?+
The most critical adverse reactions include cholinergic crisis, severe bradycardia, bronchospasm, hypotension, and allergic anaphylaxis. These events can be life‑threatening and require immediate medical intervention, such as atropine administration for bradycardia or airway support for bronchospasm. Patients should be monitored closely during and after dosing.
Who should not use Miostin?+
Miostin is contraindicated in individuals with known hypersensitivity to neostigmine or any component of the formulation. It should be used with caution, or avoided, in patients with severe asthma, chronic obstructive pulmonary disease, bradyarrhythmias, or recent myocardial infarction, as the cholinergic effects may exacerbate these conditions. Clinical judgment determines suitability.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Neostigmine Methylsulfate
Route
Intramuscular Use , Intravenous Use , Subcutaneous
Manufacturer
Zentiva S.A.
Origin
EU

Related products

NEOSTIGMINE METHYLSULFATE 1 mg/mL

NEOSTIGMINE METHYLSULFATE 1 mg/mL

Neostigmine Methylsulfate · 1 mg/mL

Neostigmine Methylsulfate
INJECTION
Henry Schein, Inc.
USA
NEOSTIGMINE METHYLSULFATE .5 mg/mL

NEOSTIGMINE METHYLSULFATE .5 mg/mL

Neostigmine Methylsulfate · 0.5 mg/mL

Neostigmine Methylsulfate
INJECTION
Amphastar Pharmaceuticals, Inc.
USA
NEOSTIGMINE METHYLSULFATE 1 mg/mL

NEOSTIGMINE METHYLSULFATE 1 mg/mL

Neostigmine Methylsulfate · 1 mg/mL

Neostigmine Methylsulfate
INJECTION
Amphastar Pharmaceuticals, Inc.
USA
Neostigmine Methylsulfate 1 mg/mL

Neostigmine Methylsulfate 1 mg/mL

Neostigmine Methylsulfate · 1 mg/mL

Neostigmine Methylsulfate
INJECTION
Hikma Pharmaceuticals USA Inc.
USA